Buscar
Mostrando ítems 1-10 de 1501
From Imitation to Innovation: A Study of China's Drug R&D and Relevant National Policies
(Universidad Alberto Hurtado. Facultad de Economía y Negocios, 2011)
Farmacovigilância no Brasil: A relação entre polimorfismo de fármacos, efetividade e segurança dos medicamentos
(2008-12-01)
In spite of the stated Brazilian policy on medicines that their quality, effectiveness and safety should be ensured at reasonable cost, hospitals in the ANVISA Surveillance Network have been receiving notifications of ...
Farmacovigilância no Brasil: A relação entre polimorfismo de fármacos, efetividade e segurança dos medicamentos
(2008-12-01)
In spite of the stated Brazilian policy on medicines that their quality, effectiveness and safety should be ensured at reasonable cost, hospitals in the ANVISA Surveillance Network have been receiving notifications of ...
Can drug repurposing strategies be the solution to the COVID-19 crisis?
(Taylor & Francis Ltd, 2020-12)
Introduction: The current COVID-19 pandemic has resulted in disastrous human and economic costs, mainly due to the absence of specific treatments to ameliorate the effects of this emerging viral disease. Complementary to ...
Pharmacokinetic tests: a public policy tool of science, technology, and innovation in pharmaceutical drugs for Brazil
(Canadian Center of Science and Education, 2019)
Computational approaches for innovative antiepileptic drug discovery
(Taylor & Francis, 2016-10)
Introduction: Despite the approval of a large number of antiepileptic agents over the past 25 years, there has been no significant improvement in efficacy of treatments, with one third of patients suffering from intractable ...